Guillermo Rocha, MD, FRCSC, FACS is originally from Mexico City, Mexico. He trained in Ophthalmology at McGill University in Montreal and has completed subspecialty training in Ocular Immunology and Inflammation, and Cornea and External Diseases. He completed the Physician CEO Executive Program at the Kellogg School of Management (2016) and the Foundations of Clinical Research Certificate Program, Harvard Medical School (2022).

He is Professor and Chair, Department of Ophthalmology & Visual Sciences at McGill University and Chief, Division of Ophthalmology at MUHC in Montréal, Canada, President of the COS Foundation, Past President of the Canadian Ophthalmological Society (2016-2018), and past President of the Canadian Cornea, External Diseases and Refractive Surgery Society. 

In 1995, he was awarded the Canadian Society for Clinical Investigation & Medical Research Council of Canada Resident Research Award for his work on the causative factors of ocular inflammation. Dr. Rocha was the recipient of the Lieutenant Governor of Manitoba iCare Award for 2014. In 2015, he was recognized as one of the 10 Most Successful Mexicans in Canada, followed by an award as one of the 10 Most Influential Hispanic Canadians in 2016. Dr. Rocha performs Anterior Segment, Refractive and Corneal Surgeries. 

Financial disclosure: Dr. Rocha has/had an affiliation (financial or otherwise) with a commercial organization:

1. AbbVie
2. Alcon
3. Allergan
4. Bausch + Lomb
5. Baxis
6. Johnson & Johnson
7. Staar
8. SunPharma
9. Labtician Ophthalmics